"Actions of Thiols, Persulfides, and Polysulfides as Free Radical Scavenging Antioxidants"
A long-acting glucose dependent insulinotropic polypeptide receptor agonist shows weight loss without nausea or vomiting, in: American Diabetes Association 83rd Annual Scientific Sessions, San Diego, CA, USA, 23 26 June 2023
Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
By setting a realistic target, choosing protein-rich foods, and tracking your intake, you can maximize the benefits of your medication while protecting your long-term health
Malhotra, MD, a functional medicine doctor and weight-loss specialist in a suburb of Chicago, confirmed that she has seen myriad health improvements in patients taking GLP-1s particularly those with diabetes who were "very sick." "We observed that this sick population was doing better than the diabetics who were on other diabetes medicines," she shared with Fox News Digital, noting that she observed improvements in brain health, memory, heart health, circulation, and liver and kidney function
doi:10.1016/j.metabol.2013.09.010 Nauck MA, Quast DR, Wefers J, Pfeiffer AFH